Abstract

BERETTA, Mario et al. Cardiac amyloidosis: value of molecular diagnostic with radiotracers. Case report. Rev.Urug.Cardiol. [online]. 2018, vol.33, n.2, pp.145-156. ISSN 0797-0048.  https://doi.org/10.29277/cardio.33.2.8.

Cardiac amyloidosis is a rare and progressive entity that results in a restrictive cardiomyopathy producing symptoms of heart failure, syncope, arrhythmias or it can be a finding of echocardiography as pseudo-hypertrophy of the left ventricle. Molecular imaging with nuclear medicine allows differentiating between the two most common types of amyloidosis without the need for endomyocardial biopsy. We present the case of a 75-year-old male with progressive dyspnea, in whom magnetic resonance imaging shows suspicion of cardiac amyloidosis, which is confirmed by scintigraphy.

Keywords : Amyloidosis; Heart diseases; Restrictive cardiomyophaty; Nuclear medicine.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )